These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23582964)

  • 1. The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia.
    Clyman RI
    Semin Perinatol; 2013 Apr; 37(2):102-7. PubMed ID: 23582964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patent ductus arteriosus, its treatments, and the risks of pulmonary morbidity.
    Clyman RI
    Semin Perinatol; 2018 Jun; 42(4):235-242. PubMed ID: 29958703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patent ductus arteriosus (PDA) and pulmonary morbidity: can early targeted pharmacologic PDA treatment decrease the risk of bronchopulmonary dysplasia?
    Clyman RI; Hills NK
    Semin Perinatol; 2023 Mar; 47(2):151718. PubMed ID: 36882361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Shah SS
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004213. PubMed ID: 31985838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Patent ductus arteriosus in premature infants].
    Bratlid D; Farstad T
    Tidsskr Nor Laegeforen; 2009 Aug; 129(15):1455-8. PubMed ID: 19690594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indomethacin for symptomatic patent ductus arteriosus in preterm infants.
    Evans P; O'Reilly D; Flyer JN; Soll R; Mitra S
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013133. PubMed ID: 33448032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003481. PubMed ID: 18254020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamically significant patent ductus arteriosus and the development of bronchopulmonary dysplasia.
    Willis KA; Weems MF
    Congenit Heart Dis; 2019 Jan; 14(1):27-32. PubMed ID: 30343505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ibuprofen--a new application for pharmacological closure of patent ductus arteriosus in preterm infants. Preliminary report].
    Adamska E
    Med Wieku Rozwoj; 2000; 4(2 Suppl 3):65-71. PubMed ID: 11328971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morbidities associated with patent ductus arteriosus in preterm infants. Nationwide cohort study.
    Härkin P; Marttila R; Pokka T; Saarela T; Hallman M
    J Matern Fetal Neonatal Med; 2018 Oct; 31(19):2576-2583. PubMed ID: 28651469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial).
    Hundscheid T; Onland W; van Overmeire B; Dijk P; van Kaam AHLC; Dijkman KP; Kooi EMW; Villamor E; Kroon AA; Visser R; Vijlbrief DC; de Tollenaer SM; Cools F; van Laere D; Johansson AB; Hocq C; Zecic A; Adang E; Donders R; de Vries W; van Heijst AFJ; de Boode WP
    BMC Pediatr; 2018 Aug; 18(1):262. PubMed ID: 30077184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
    Malviya M; Ohlsson A; Shah S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003951. PubMed ID: 18254035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial.
    Clyman R; Cassady G; Kirklin JK; Collins M; Philips JB
    J Pediatr; 2009 Jun; 154(6):873-6. PubMed ID: 19324366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
    Malviya M; Ohlsson A; Shah S
    Cochrane Database Syst Rev; 2003; (3):CD003951. PubMed ID: 12917997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of pharmacological treatment for patent ductus arteriosus and risk of secondary surgery, death or bronchopulmonary dysplasia: a population-based cohort study of extremely preterm infants.
    Gudmundsdottir A; Johansson S; Håkansson S; Norman M; Källen K; Bonamy AK
    Neonatology; 2015; 107(2):87-92. PubMed ID: 25412681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants.
    ElHassan NO; Bird TM; King AJ; Ambadwar PB; Jaquiss RD; Kaiser JR; Robbins JM
    J Neonatal Perinatal Med; 2014 Jan; 7(3):229-35. PubMed ID: 25322995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Shah SS
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004213. PubMed ID: 31222841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of patent ductus arteriosus shunt size and duration on risk of death or severe respiratory morbidity in preterm infants born in China.
    Deng Y; Zhang H; Zhao Z; Du J; Bai R; McNamara PJ
    Eur J Pediatr; 2022 Aug; 181(8):3131-3140. PubMed ID: 35838780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes.
    Liebowitz M; Clyman RI
    J Pediatr; 2017 Aug; 187():119-126.e1. PubMed ID: 28396025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patent ductus arteriosus and the risk of bronchopulmonary dysplasia-associated pulmonary hypertension.
    Nawaytou H; Hills NK; Clyman RI
    Pediatr Res; 2023 Aug; 94(2):547-554. PubMed ID: 36804505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.